Table 1.
Inactive SLE (n = 15) | Active SLE (n = 21) | |
---|---|---|
Age (mean, range) | 40.4 ± 1.7 (28-69) | 33.8 ± 1.7 (12-68) |
Disease duration (years) | 6.8 ± 0.7 | 5.4 ± 0.6 |
SLEDAI (range) | 0-6 | 7-25 |
C3 (mean ± SEM, mg/dL) | 97.0 ± 9.3 | 65.3 ± 4.5 |
C4 (mean ± SEM, mg/dL) | 23.3 ± 3.0 | 11.2 ± 1.7 |
Anti-ds DNA (mean ± SEM, mg/dL) | 170.7 ± 34.1 | 370.0 ± 39.3 |
Malar rash (%) | 29.2% | 31.8% |
Nephritis (%) | 32.9% | 51.6% |
Arthritis (%) | 71.8% | 33.9% |
Prednisolone (mg/day) | 7.5 ± 1.1 | 12.5 ± 1.7 |
Azathioprine (%) | 13.3% | 30.0% |
Mycophenolate mofetil (%) | 5.0% | 3.2% |